Milestone Pharmaceuticals (MIST) Cash & Equivalents: 2021

Historic Cash & Equivalents for Milestone Pharmaceuticals (MIST) over the last 1 years, with Dec 2021 value amounting to $114.1 million.

  • Milestone Pharmaceuticals' Cash & Equivalents fell 38.92% to $77.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $77.2 million, marking a year-over-year decrease of 38.92%. This contributed to the annual value of $114.1 million for FY2021, which is N/A change from last year.
  • According to the latest figures from FY2021, Milestone Pharmaceuticals' Cash & Equivalents is $114.1 million.
  • In the past 5 years, Milestone Pharmaceuticals' Cash & Equivalents registered a high of $114.1 million during FY2021, and its lowest value of $114.1 million during FY2021.
  • In the last 1 years, Milestone Pharmaceuticals' Cash & Equivalents had a median value of $114.1 million in 2021 and averaged $114.1 million.